semaj83/ctmatch_classification huggingface dataset:
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Intraepithelial Neoplasia Histologically proven CIN 2 or CIN 3, without invasion after previous surgical treatment at least 6 months before diagnosis Histologically proven recurrent CIN 1 after previous surgical treatment at least 6 months before diagnosis. Persistent CIN 1 is defined as CIN 1 at least persistent for 6 months and proven with histology The patient is willing to use a medically acceptable method of contraception throughout the study Women older than 18 years of age  Pregnancy or lactation (Micro-)invasive carcinoma Past history of cervical cancer Hypersensitivity of any components of the formulation History of psoriasis or other inflammatory dermatosis of the vulva Immunodeficiency or treatment with immunosuppressive medication Insufficient understanding of the Dutch or English language
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Nicotine Dependence Alcohol Use Disorder Be treatment-seeking for smoking cessation and have a desire to reduce or quit drinking 2. Be between the ages of 21 and 65 3. Be able to provide informed consent 4. Smoke 5 or more cigarettes per day for the past year 5. Currently drink heavily according to the National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines: for men, > 14 drinks per week or ≥ 5 drinks per occasion at least once per month over the past 12 months; for women, > 7 drinks per week or ≥ 4 drinks per occasion at least once per month over the past 12 months 6. Pass the physical exam and associated laboratory tests, as determined by study physician  Have clinically significant alcohol withdrawal, indicated by a score ≥ 10 on the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) and assessed at the in-person screening visits 2. Have lifetime DSM-V diagnosis of schizophrenia, bipolar disorder, a psychotic disorder, or any other psychiatric disorder as determined by the clinical interview 3. Have major depressive disorder within the past year requiring treatment as determined by the clinical interview using DSM-V 4. Have a current or lifetime DSM-V diagnosis of a substance use disorder, other than for alcohol or nicotine, as determined by the clinical interview 5. Have a prior history of taking FDA approved medications (i.e. varenicline or bupropion) for smoking cessation 6. Be currently using any forms of nicotine replacement therapy (past use is acceptable) 7. Be currently using tobacco products other than cigarettes (such as e-cigarettes, cigars, or chewing tobacco) 8. Have a serious medical illness (significant cardiovascular disease; uncontrolled hypertension; hepatic or renal disease) that would contraindicate participation, as determined by the study physician 9. Be currently taking insulin or oral hypoglycemic medication 10. Be currently taking opioid pain medications or any form of opioid agonist maintenance therapy (such as methadone or buprenorphine) 11. Be currently taking any other psychoactive medications; such as anti-depressants, mood stabilizers, anti-seizure medications, sedatives-hypnotics, anxiolytics, stimulants or antipsychotics 12. Have self-reported use of cocaine, methamphetamine, heroin or other illicit drugs in the previous 60 days, verified by urine toxicology screen 13. For women, must not be pregnant (as indicated by self-report or a positive pregnancy test at any study visit), nursing, or planning to become pregnant while taking part in the study, and must agree to a reliable method of birth control
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 25.0-64.0,  Cervical Cancer Female 64 year old Women scheduled for a colposcopy exam due to abnormal cytology result according to the Bethesda classification 2001 (NILM, AGC (Atypical Glandular Cells), ASC-US (Atypical Squamous Cells of Undetermined Significance), ASC-H (Atypical Squamous Cells cannot HSIL), LSIL (Low-grade Squamous Intraepithelial Lesion), HSIL (High-grade Squamous Intraepithelial Lesion), invasive carcinoma), and/or positive for hrHPV infection. NILM (Negative for Intraepithelial Lesion or Malignancy) are only included when positive for hrHPV infection Signing informed consent form (ICF) Giving consent to the research team (CEV) to contact his/her general practioner and/or gynaecologist to access details of the participants HPV vaccination (schedule) and results of cervical smears/cytology, HPV tests, colposcopy, and biopsy (included in ICF)  Participating in another clinical study at the same time of participating in this study Not able to understand the information brochure/what the study is about Anything in the opinion of the investigator that would prevent volunteers from completing the study or put the volunteer at risk
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Malignant Neoplasms of Female Genital Organs Women with an abnormal Pap test, positive HPV test or any history of cervical dysplasia 2. Women with an intact cervix (patients who have undergone previous LEEP, cone and/or cryotherapy are eligible) 3. Women of childbearing potential must have a negative urine or serum pregnancy test 4. Women who are at least 21 years of age or older 5. Ability to understand and the willingness to provide informed consent and sign a written Informed Consent Document (ICD) 6. For patients that present to clinic to have a cervical excisional procedure (LEEP) for an already confirmed diagnosis of high grade cervical dysplasia, HRME imaging study will be performed and cervical biopsies might be taken for research purposes only. Since these patients have already the confirmed diagnosis of high-grade cervical dysplasia, any extra biopsies taken will be for research purposes only and our research fund will pay them  Women < 21 years of age 2. Women who have undergone a hysterectomy with removal of the cervix 3. Women with a known allergy to proflavine, acriflavine, or iodine 4. Women who are pregnant or nursing 5. Patients unable or unwilling to provide informed consent or sign a written Informed Consent Document (ICD)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Women With Abnormal Pap Smears Subjects capable of giving informed consent or have an acceptable surrogate capable of giving consent on subjects behalf Subjects are 18 years of age or older Subjects are scheduled for colposcopy clinic based on screening with abnormal pap smear or have repeat colposcopy indicated for specific clinical indications, based off of American Society of Cosposcopy and Cytology Subjects are women  Pregnancy Males (males do not have a cervix and thus cannot undergo colposcopy)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Intra-epithelial Neoplasia Grade 1 or Worse attending colposcopy clinic biopsy-proven CIN1+ lesion understands study procedures and accepts voluntarily to participate by signing the informed consent form  pregnancy
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  Cervical HPV-16 and / or HPV-18 Infection Age 25 to 65 years of age with the sex life of female patients HPV DNA typing test for HPV-16 and/ or HPV-18 positive in 1 month  Patients with cervical intraepithelial neoplasia Ⅱ / Ⅲ, cervical cancer Associated with fungal vaginitis, trichomonas vaginitis, HIV positive patients Associated with acute, severe bacterial or viral infection Autoimmune diseases Within 3 months before screening patients used corticosteroids, immunosuppressants or other antiviral drugs Allergies or allergy to the drug known ingredients History of suffering CNS diseases, epilepsy and/or psychological disorder Pregnant and lactating women The researchers do not consider it appropriate clinical trials
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  Human Papilloma Virus Infection Cervical Intraepithelial Neoplasia Grade 2/3 women previously positive at HPV testing  pregnancy
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 25.0-999.0,  Menopause Migraine years old or above Healthy women  Those with history of present illness Past history of significant neurological and psychiatric disorders or MRI contraindication
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Human Immunodeficiency Virus (HIV) Human Papillomavirus (HPV) Currently enrolled in the Women's HIV Interagency Study (WIHS) study Able and willing to undergo anal cytology, anal molecular testing, and high resolution anoscopy with targeted anal biopsies  History of high grade anal intraepithelial neoplasia (AIN 2 or 3) History of active anal disease requiring surgery History of anal or cervical cancer
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Lichen Sclerosus Lichen Sclerosus et Atrophicus Patients seen at Northwestern Medicine Department of Dermatology and/or Department of Obstetrics and Gynecology, who were seen by Dr. Bethanee Schlosser, and/or other members of the Vulvar Mucosal Specialty Clinic team in any of their respective clinic settings and underwent complete mucocutaneous examination Patients with histologically confirmed vulvar LS  Patients who refuse complete mucocutaneous examination Patients who refuse recommended diagnostic procedures Pregnant women or prisoners
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Neoplasm, Trophoblastic Gestational Trophoblastic Disease Hydatidiform Mole Hydatidiform Mole, Invasive Patients are eligible if they have a histologically proven trophoblastic disease, or a diagnosis of gestational trophoblastic neoplasia done on an abnormal evolution of hCG  none
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Ectropion patients underwent eyelid ectropion surgery
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Uterine Cervical Dysplasia histologically proven cervical dysplasia colposcopy Prior to conization informed consent  significant language barrier a personal history of conization pregnancy the use of blood thinner unwillingness to participate
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-88.0,  Chronic Kidney Disease Acute Kidney Injury Heart Disease Patients scheduled to undergo non-emergent cardiac catheterization at University Medical Center Hospital, Lubbock, TX from January 2016 to January 2018. Emergent cardiac catheterizations will be defined as a catheterization scheduled < 24 hours from a cardiac event. 2. Patients willing to be randomized to TFA or TRA procedure. 3. Patients signed and dated the informed consent agreeing to participate in the study. 4. Patients with chronic kidney disease, defined as eGFR = 15-59mL/min defined by the MDRD formula. (eGFR is a standard of care measurement for all patients undergoing coronary intervention.). 5. Patients ages 18-88 years old  Patients who have previously undergone a coronary artery bypass graft procedure. 2. Patients with prior catheterization within the last 5 years. 3. Women who are pregnant or expect to become pregnant. Pregnancy tests for women of childbearing potential (WOCHP) will be performed as standard of care. 4. Patients with a history of cardiogenic shock. 5. Children (under the age of 18). 6. Medical, geographical, or social factors making study participation impractical, i.e. documented noncompliance, unable to return for follow-ups and lab draws, etc. 7. A positive Allen's Test on the right radial artery. 8. Any condition preventing TRA or TFA access. 9. Contrast used within the previous 3 weeks. 10. Allergy to contrast dye. 11. Inability to successfully access the artery randomized to use
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Stress Disorders, Post-Traumatic Intimate Partner Violence Alcohol-Related Disorders Female Veterans Lifetime history of ST with at least one risk factor: heavy drinking within the past 3 months, screen positive for current PTSD or for IPV within last 12 months Age 18-65 Seeking treatment through the Women's Primary Care Clinics at the Central Texas VA Healthcare System Ability to understand study procedures in English Not actively in suicidal or homicidal crisis warranting imminent hospitalization
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Status Epilepticus Anaphylaxis Residents (PGY1 to PGY4) Completing a rotation in pediatric emergency  Residents who previously participated in this study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-100.0,  Valvular Heart Disease Stenosis and Regurgitation (Diagnosis) Presence of aortic stenosis, mitral or aortic regurgitation at the time of an echocardiography at the "Cliniques Universitaires Saint Luc"
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Smoking Cessation Alcohol Drinking currently meet for DSM-5 mild to moderate alcohol use disorder (meeting 2-5 for AUD) have been engaging in hazardous drinking over the past month, defined as either exceeding a mean of 14 standard drinks/wk for men, 7 drinks/wk for women; or by consuming >5 on at least one occasion in the last month for men, >4 drinks on at least one occasion in the last month for women currently smoke >10 cigarettes a day, and have smoked for at least one year can speak and write fluent conversational English are willing to make an attempt to quit both alcohol and smoking  are expected to have unstable medication regimen during the study are currently receiving non-study behavioral treatment for alcohol use disorder or smoking have severe alcohol use disorder (meeting >6 for AUD or having alcohol withdrawal symptom criterion) have AUD that is in early remission, with no symptoms evident over the past month have experienced myocardial infarction in past 6 months contraindication to nicotine replacement therapy with no medical clearance to participate in the study use other forms of nicotine such as cigars, pipes, or chewing tobacco are currently pregnant have a primary psychotic disorder or current manic episode have had substance use disorder (other than alcohol or nicotine) in the preceding 3 months
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 16.0-20.0,  Human Papillomavirus Human Papillomavirus Infection Men aged 16 to 20 (Must be aged 16-19 years from 1 January 2017 to 31 December 2017, and aged 16-20 years from 1 January 2018 to 31 December 2018) Report any previous type of sexual contact (including but not restricted to oral or anal sex) with at least one other man ever Able to complete all study requirements including questionnaire in English and completion of 2 visits Residing in Australia since 2013 (This is to ensure that males included in the study were present in Australia at the time HPV vaccination was offered)  Transgender male
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  Cervical Cancer Screening Self-identify as lesbian, bisexual, or queer woman Assigned female sex at birth English speaking ages 25-65 years report not having had a pap smear in the last three years (per guidelines) if age 30 or over, report not having a pap smear/HPV co-test within the past 5 years (per guidelines)  report having had a hysterectomy report having history of cervical cancer unable to consent Pregnant women Prisoners
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cystic Fibrosis Female with Cystic fibrosis Age 18 years or older transplanted or non-transplanted Accepting the principle of a gynecological consultation and the principle of follow-up every 6 months in case of abnormal smear or positive HPV test Patient covered by health insurance  Age under 18 Refusal to participate in the study Patient under tutorship / curatorship